ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan

Mutations of the BCR-ABL tyrosine kinase domain constitute a major cause of resistance to tyrosine kinase inhibitors in patients with chronic myelogenous leukemia (CML). In this study, we analyzed peripheral blood samples from 185 Jordanian CML patients for ABL mutations, who were on imatinib for a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Awidi, Abdalla, Ababneh, Nidaa, Magablah, Ahmad, Bsoul, Nazzal, Mefleh, Razan, Marei, Lina, Abbasi, Salah
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc. 2012
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3483047/
https://ncbi.nlm.nih.gov/pubmed/23009571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/gtmb.2012.0147
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller